When was Aahi founded?

Aahi was founded in 1993 and raised its 1st funding round within a year of its incorporation.

Where is Aahi located?

Aahi is headquartered in Seattle, United States. It is registered at Seattle, Washington.

How many employees does Aahi have?

As of Sep 30, 2026, the latest employee count at Aahi is 11.

Is Aahi a funded company?

Aahi is a funded company, having raised an undisclosed amount across 28 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Nov 01, 1993.

When was the latest funding round of Aahi?

Aahi's latest funding was a $***** Grant (prize money) round on Sep 30, 2018, with participation from 1 investor.

Where does Aahi rank among its competitors?

Aahi ranks 6th amongst 33 active competitors, of which 7 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Xanadu Bio, which secured $11M in Aug, 2025.

Who are the top competitors of Aahi?

Aahi's top competitors include Dynavax, Sinovac and Curevo. Among them, Xanadu Bio secured the most recent funding round in August, 2025.

Aahi - 2026 Company Profile, Funding & Competitors

Aahi is a funded company based in Seattle (United States), founded in 1993. It operates as a Nonprofit research institute developing accessible vaccine technologies and medical solutions. Aahi has raised an undisclosed amount in funding. The company has 33 active competitors, including 7 funded and 4 that have exited. Its top competitors include companies like Dynavax, Sinovac and Curevo.

Company Details

Nonprofit research institute developing accessible vaccine technologies and medical solutions. This organization focuses on translating scientific research into practical, scalable treatments to address infectious diseases. Activities include creating dry vaccine formulations to reduce dependency on cold chain logistics and designing needle-free delivery systems for improved protection against respiratory illnesses. By collaborating with external partners, the institute works to ensure that medical innovations reach underserved populations. Research initiatives also extend to immune-enhancing platforms for cancers, autoimmune disorders, and allergies. The organization operates with a primary goal of alleviating disease through scientific development and systematic deployment.

Website: www.aahi.org/
Phone Number: +1 **********
Registered Address: Seattle, Washington

Key Metrics

Founded Year

1993

Location

Seattle, United States

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Sep 30, 2018, $*****

Investors

Gates & 3 more

Ranked

6^th among 33 active competitors

Employee Count

11 as on Sep 30, 2026

Similar Companies

Dynavax & 31 more

View Aahi's full profile

Aahi is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Infectious Disease Research Institute CIN: 911608978 , United States, Active	Dec 31, 1999	-	69 (As on Dec 31, 2024)	-

Aahi has raised funding over 28 rounds. Its first funding round was on Nov 01, 1993. Its latest funding round was a Grant (prize money) round on Sep 30, 2018 for $*****. 1 investor participated in its latest round. Aahi has 4 institutional investors.

Here is the list of recent funding rounds of Aahi:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 30, 2018	7099618	Grant (prize money)	1804108	4685040	9556160	3055446
Feb 01, 2018	7930937	Grant (prize money)	4929429	6480684	3111792	Europa
Aug 15, 2016	6237715	Grant (prize money)	8500922	5131266	8425189	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Aahi's funding rounds and investors

Aahi's employee count trend

Aahi has 11 employees as of Sep 26. Here is Aahi's employee count trend over the years:

Uncover Aahi's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Aahi include Dynavax, Sinovac and Curevo. Here is the list of Top 10 competitors of Aahi, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Dynavax 1996, Berkeley (United States), Acquired	Developer of products to prevent and treat infectious and inflammatory diseases and cancer	$73.9M	Care Capital, Axiom Venture Partners & 27 others	70/100
2nd	Sinovac 2001, Haidian (China), Acquired	Developer of vaccines against multiple infectious diseases	-	Vivo Capital, Sino Biopharmaceutical & 3 others	64/100
3rd	Curevo 2017, Seattle (United States), Series B	Developer of non-mRNA adjuvanted subunit vaccines for infectious disease prevention	$196M	RA Capital Management, Janus Henderson Investors ... & 9 others	56/100
4th	Cellevate 2014, Lund (Sweden), Seed	Developer of nanofiber-based cell culture products for upstream bioprocessing	$7.09M	Industrifonden, Smile Incubator & 3 others	53/100
5th	Evaxion Biotech 2008, Horsholm (Denmark), Public	Developer of AI-Immunology™ platform for vaccine target discovery, design, and development	-	-	49/100
6th	Aahi 1993, Seattle (United States), Funding Raised	Nonprofit research institute developing accessible vaccine technologies and medical solutions	-	Gates, Military Health & 2 others	45/100
7th	Xanadu Bio 2021, United States, Series B	Delivery of nanoparticle system for mRNA and other payload delivery	$23M	-	43/100
8th	Abogen Biosciences 2019, Suzhou (China), Series C	Developer of mRNA-based therapeutics for cancer and infectious diseases	$1.13B	Hillhouse, SDIC Venture Capital Management ... & 40 others	42/100
9th	Chain Biotech 2014, Nottingham (United Kingdom), Seed	Developer of microbiome-based oral immunotherapies	$5.88M	BGF, SynBioVen & 43 others	39/100
10th	Emervax 2022, Galveston (United States), Unfunded	Developer of vaccines for viruses and chronic diseases	-	-	32/100